{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:50:28Z","timestamp":1774493428871,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Varicella is considered a mild and self-limiting disease, but, in some cases, it may complicate and require hospitalization. Antibiotics are not the first line therapy but in some cases are prescribed either for the management of varicella-related complications or as a preventive strategy. Aim of this study is to analyze the rate and the patterns of antibiotics used in pediatric patients hospitalized for varicella as well as the relative costs in order to increase insights in antibiotic use in varicella.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients less than 18\u00a0years hospitalized for varicella at the Bambino Ges\u00f9 Children\u2019s IRCCS Hospital in Rome, Italy, from the 1<jats:sup>st<\/jats:sup> of November 2005 to the 1<jats:sup>st<\/jats:sup> of November 2021 entered the study. Retrospective data were collected from the hospital's database electronic medical records. The rate, the patterns and the costs of antibiotics used were considered.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>According to the inclusion criteria, we enrolled 810 patients, with a median age of 2.4\u00a0years. Out of them, 345 patients (42.6%) underwent antibiotic therapy, of which 307 for a complication (90.0%) and the other 10.0%, antibiotic for the fear of developing complications. The cost for varicella hospitalizations was EUR 2,928,749 (median cost EUR 2689). As for antibiotic therapy, it represented the 5.9% of the total cost (EUR 174,527), with a median cost of EUR 198.8. The cost in patients who underwent antibiotic therapy was significantly higher than in those who did not (<jats:italic>p<\/jats:italic>-value\u2009&lt;\u20090.0001), as well as the hospitalization length (<jats:italic>p<\/jats:italic>-value\u2009&lt;\u20090.0001). The most commonly prescribed antibiotics were Amoxicillin-clavulanate and Ceftriaxone, which represented the 36.0% and 25.0% of all antibiotic prescription, respectively.<\/jats:p>\n                <jats:p>Antibiotics may negatively affect the economic cost of hospitalization and the prescription is not always in accordance to guidelines, with potential important repercussions on the development of antimicrobial resistance. Actually, resistance to antibiotics is considered a major risk to the future health of the world population as it may lead to longer hospital stay, increased risk of mortality, health care costs and treatment failures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Strategies to reduce economical cost, hospitalization length and antimicrobial resistance include ensuring appropriate prescription and administration of empiric antibiotics as well as reducing the circulation of preventable infectious diseases through immunization.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-022-01393-5","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T04:12:33Z","timestamp":1670818353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessing the use of antibiotics in pediatric patients hospitalized for varicella"],"prefix":"10.1186","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2586-019X","authenticated-orcid":false,"given":"Elena","family":"Bozzola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Marchesani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ficari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Brusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Spina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosaria","family":"Marchili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Guolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"1393_CR1","first-page":"259","volume":"50","author":"M Riaza G\u00f3mez","year":"1999","unstructured":"Riaza G\u00f3mez M, de la Torre EM, Menc\u00eda Bartolom\u00e9 S, Molina Caba\u00f1ero JC. Tamariz-Martel Moreno A [Complications of varicella in children]. An Esp Pediatr. 1999;50:259\u201362.","journal-title":"An Esp Pediatr"},{"key":"1393_CR2","first-page":"1533","volume":"29","author":"B Elena","year":"2011","unstructured":"Elena B, Anna Q, Andrzej K, Elisabetta P, Laura L, Alberto T. Short communication: Haematological complications in otherwise healthy children hospitalized for varicella. Vaccine Elsevier BV. 2011;29:1533\u20137.","journal-title":"Vaccine Elsevier BV"},{"key":"1393_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jped.2016.05.001","volume":"92","author":"E Bozzola","year":"2016","unstructured":"Bozzola E, Bozzola M. Varicella complications and universal immunization. J Pediatr (Rio J). 2016;92:328\u201330.","journal-title":"J Pediatr (Rio J)"},{"key":"1393_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0022-3476(05)82495-3","volume":"120","author":"HH Balfour","year":"1992","unstructured":"Balfour HH, Rotbart HA, Feldman S, Dunkle LM, Feder HM, Prober CG, et al. Acyclovir treatment of varicella in otherwise healthy adolescents. JPediatr Elsevier. 1992;120:627\u201333.","journal-title":"JPediatr. Elsevier"},{"key":"1393_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/infdis\/157.2.309","volume":"157","author":"G Nyerges","year":"1988","unstructured":"Nyerges G, Meszner Z, Gyarmati E, Kerpel-Fronios S. Acyclovir Prevents Dissemination of Varicella in Immunocompromised Children. J Infect Dis. 1988;157:309\u201313.","journal-title":"J Infect Dis"},{"key":"1393_CR6","doi-asserted-by":"publisher","first-page":"12053","DOI":"10.3390\/ijerph182212053","volume":"18","author":"E Bozzola","year":"2021","unstructured":"Bozzola E, Spina G, Marchili MR, Brusco C, Guolo S, Rossetti C, et al. Pediatric Hospitalization for Varicella in an Italian Pediatric Hospital: How Much Does It Cost? Int J Environ Res Public Health. 2021;18:12053.","journal-title":"Int J Environ Res Public Health"},{"key":"1393_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.287.5.606","volume":"287","author":"JF Seward","year":"2002","unstructured":"Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000. JAMA. 2002;287:606\u201311.","journal-title":"JAMA"},{"key":"1393_CR8","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1186\/s12889-019-7071-z","volume":"19","author":"LJ Wolfson","year":"2019","unstructured":"Wolfson LJ, Castillo ME, Giglio N, M\u00e9szner Z, Moln\u00e1r Z, V\u00e0zquez M, et al. The use of antibiotics in the treatment of pediatric varicella patients: real-world evidence from the multi-country MARVEL study in Latin America & Europe. BMC Public Health. 2019;19:826.","journal-title":"BMC Public Health"},{"key":"1393_CR9","unstructured":"Pinkbook: Varicella.CDC. 2021. https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/varicella.html. Accessed 10 Jul 2022."},{"issue":"1","key":"1393_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/INF.0000000000001356","volume":"36","author":"A Streng","year":"2017","unstructured":"Streng A, Grote V, Rack-Hoch A, Liese J. Decline of Neurologic Varicella Complications in Children During the First Seven Years After Introduction of Universal Varicella Vaccination in Germany, 2005\u20132011. Pediatr Infect Dis J. 2017;36(1):79\u201386.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"1393_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.rpped.2015.12.006","volume":"34","author":"M Hirose","year":"2016","unstructured":"Hirose M, Gilio A, Ferronato AE, Ragazzi SL. The impact of varicella vaccination on varicella-related hospitalization rates: global data review. Revista paulista de pediatria\u202f: orgao oficial da Sociedade de Pediatria de Sao Paulo. 2016;34(3):359\u201366.","journal-title":"Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo"},{"key":"1393_CR12","doi-asserted-by":"crossref","unstructured":"Spoulou V, Alain S, Gabutti G, Giaquinto C, Liese J, Martinon-Torres F, et al. Implementing Universal Varicella Vaccination in Europe: The Path Forward. PEDIATRIC INFECTIOUS DISEASE JOURNAL.2018 https:\/\/researchportal.tuni.fi\/en\/publications\/implementing-universal-varicella-vaccination-in-europe-the-path-f. Accessed on 10 Jul 2022.","DOI":"10.1097\/INF.0000000000002233"},{"key":"1393_CR13","doi-asserted-by":"publisher","first-page":"e0269916","DOI":"10.1371\/journal.pone.0269916","volume":"17","author":"M Pawaskar","year":"2022","unstructured":"Pawaskar M, Fergie J, Harley C, Samant S, Veeranki P, Diaz O, et al. Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States. PLOS ONE. 2022;17:e0269916 Public Library of Science.","journal-title":"PLOS ONE"},{"key":"1393_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/CEOR.S229685","volume":"12","author":"C Azzari","year":"2020","unstructured":"Azzari C, Baldo V, Giuffrida S, Gani R, O\u2019Brien E, Alimenti C, et al. The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies. Clinicoecon Outcomes Res. 2020;12:273\u201383.","journal-title":"Clinicoecon Outcomes Res"},{"key":"1393_CR15","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1080\/21645515.2021.1969853","volume":"17","author":"F Marchetti","year":"2021","unstructured":"Marchetti F, Prato R, Viale P. Survey among Italian experts on existing vaccines\u2019 role in limiting antibiotic resistance. Hum Vaccin Immunother Taylor & Francis. 2021;17:4283\u201390.","journal-title":"Hum Vaccin Immunother. Taylor & Francis"},{"key":"1393_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12889-018-5298-8","volume":"18","author":"J Wysocki","year":"2018","unstructured":"Wysocki J, Malecka I, Stryczynska-Kazubska J, Rampakakis E, Kuter B, Wolfson LJ. Varicella in Poland: economic burden in children 1\u201312 years of age in Poland, 2010\u20132015. BMC Public Health. 2018;18:410.","journal-title":"BMC Public Health"},{"key":"1393_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1586\/14760584.7.6.753","volume":"7","author":"MH Rozenbaum","year":"2008","unstructured":"Rozenbaum MH, van Hoek AJ, Vegter S, Postma MJ. Cost-effectiveness of varicella vaccination programs: an update of the literature. Expert Rev Vaccines. 2008;7:753\u201382.","journal-title":"Expert Rev Vaccines"},{"key":"1393_CR18","first-page":"e567","volume":"21","author":"MH Ebell","year":"2015","unstructured":"Ebell MH, Radke T. Antibiotic use for viral acute respiratory tract infections remains common. Am J Manag Care. 2015;21:e567-575.","journal-title":"Am J Manag Care"},{"key":"1393_CR19","unstructured":"Varicella-Zoster Virus Infections. In: Committee on Infectious Diseases, American Academy of Pediatrics, David W. Kimberlin, MD, FAAP, Elizabeth D. Barnett, MD, FAAP, Ruth Lynfield, MD, FAAP, Mark H. Sawyer, MD, FAAP. Red Book: 2021\u20132024 Report of the Committee on Infectious Diseases. p. 831- 832"},{"key":"1393_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s13671-021-00334-5","volume":"10","author":"T Patel","year":"2021","unstructured":"Patel T, Quow K, Cardones AR. Management of Infectious Emergencies for the Inpatient Dermatologist. Curr Dermatol Rep. 2021;10:232\u201342.","journal-title":"Curr Dermatol Rep"},{"key":"1393_CR21","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1186\/s12879-021-06848-4","volume":"21","author":"J Vandenhaute","year":"2021","unstructured":"Vandenhaute J, Tsakeu E, Chevalier P, Pawaskar M, Ben\u010dina G, Vertriest J. Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis. BMC Infect Dis. 2021;21:1150.","journal-title":"BMC Infect Dis"},{"key":"1393_CR22","unstructured":"CDC. What You Should Know About Antibiotics. Centers for Disease Control and Prevention. 2022 https:\/\/www.cdc.gov\/antibiotic-use\/q-a.html. Accessed 18 Jul 2022."},{"key":"1393_CR23","unstructured":"L\u2019uso degli antibiotici in Italia - Rapporto Nazionale anno 2019. https:\/\/www.aifa.gov.it\/-\/l-uso-degli-antibiotici-in-italia-rapporto-nazionale-anno-2019. Accessed on 18 Jul 2022."},{"key":"1393_CR24","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1093\/jac\/dkv418","volume":"71","author":"A Versporten","year":"2016","unstructured":"Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H, ARPEC project group. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother. 2016;71:1106\u201317.","journal-title":"J Antimicrob Chemother"},{"key":"1393_CR25","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/archinte.163.8.972","volume":"163","author":"MT Hecker","year":"2003","unstructured":"Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003;163:972\u20138.","journal-title":"Arch Intern Med"},{"key":"1393_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1473-3099(10)70027-X","volume":"10","author":"MEJL Hulscher","year":"2010","unstructured":"Hulscher MEJL, Grol RPTM, van der Meer JWM. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis. 2010;10:167\u201375.","journal-title":"Lancet Infect Dis"},{"key":"1393_CR27","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1542\/peds.2011-1337","volume":"128","author":"AL Hersh","year":"2011","unstructured":"Hersh AL, Shapiro DJ, Pavia AT, Shah SS. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics. 2011;128:1053\u201361.","journal-title":"Pediatrics"},{"key":"1393_CR28","unstructured":"CDC. Chickenpox for HCP. Centers for Disease Control and Prevention. 2021. https:\/\/www.cdc.gov\/chickenpox\/hcp\/index.html. Accessed on 18 Jul 2022."},{"key":"1393_CR29","unstructured":"Damm O, Witte J, Wetzka S, Prosser C, Braun S, Welte R, et al. Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review. Int J Public Health. 2016. https:\/\/pub.uni-bielefeld.de\/record\/2905960. Accessed on 18 Jul 2022."},{"issue":"9","key":"1393_CR30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/INF.0b013e31829ae263","volume":"32","author":"JG Liese","year":"2013","unstructured":"Liese JG, Cohen C, Rack A, et al. The effectiveness of varicella vaccination in children in Germany: a case-control study. Pediatr Infect Dis J. 2013;32(9):998\u20131004.","journal-title":"Pediatr Infect Dis J"},{"key":"1393_CR31","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.4161\/hv.25228","volume":"9","author":"B Unim","year":"2013","unstructured":"Unim B, Saulle R, Boccalini S, Taddei C, Ceccherini V, Boccia A, et al. Economic evaluation of Varicella vaccination: results of a systematic review. Hum Vaccin Immunother. 2013;9:1932\u201342.","journal-title":"Hum Vaccin Immunother"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01393-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-022-01393-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01393-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T07:11:42Z","timestamp":1671088302000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-022-01393-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1186\/s13052-022-01393-5","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}